tretinoin 10 MG Oral Capsule

RxCUI
199159
RxNorm name
tretinoin 10 MG Oral Capsule
Display name
Tretinoin (Oral Pill)
Full name
tretinoin 10 MG Oral Capsule
Term type
SCD
Status
Active
Strength
10 mg
Dose form
Cap
Route
Oral Pill
Updated
2026-11-04 11:30:27

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
042005
Active start
042005
Multiple ingredient
NO
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
tretinoin10 MG / 1 EACHtretinointretinoin

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Oral Capsule316965

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
tretinoin10753

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STRtretinoin 10 MG Oral Capsule1NAMES
RxNorm Nametretinoin 10 MG Oral Capsule1NAMES
TTYSCD1ATTRIBUTES
SPL_SET_ID
5 linked values
5CODES
RxCUI1991591CODES
MMSL_CODE
2 linked values
2CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDCProduct NDCNameLabelerApplication
0904-6867-040904-6867Tretinoin TretinoinMajor PharmaceuticalsANDA201687
10370-268-0110370-268Tretinoin TretinoinPar Health USA, LLCANDA201687
68084-075-2168084-075Tretinoin TretinoinAmerican Health PackagingANDA201687
68462-792-0168462-792Tretinoin TretinoinGlenmark Pharmaceuticals Inc., USAANDA208279
72162-1220-172162-1220Tretinoin TretinoinBryant Ranch PrepackANDA201687
72162-1220-372162-1220Tretinoin TretinoinBryant Ranch PrepackANDA201687

Drugs@FDA Applications#

Application, NDC, Name table
ApplicationNDCNameMarketing categoryLabeler
ANDA2016870904-6867Tretinoin TretinoinANDAMajor Pharmaceuticals
ANDA20827968462-792Tretinoin TretinoinANDAGlenmark Pharmaceuticals Inc., USA

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 19 matching rows.

NDC11, Source, Active table
NDC11SourceActive
00555080802rxnav_ndcsyes
00904686704rxnav_ndcsyes
00904686760rxnav_ndcsyes
10370026801rxnav_ndcsyes
42291087001rxnav_ndcsyes
61269085010rxnav_ndcsyes
63629228501rxnav_ndcsyes
63629875201rxnav_ndcsyes
68084007511rxnav_ndcsyes
68084007521rxnav_ndcsyes
68462079201rxnav_ndcsyes
72162122001rxnav_ndcsyes
72162122003rxnav_ndcsyes
00004025001rxnav_historical
11014005401rxnav_historical
11014102901rxnav_historical
42291084301rxnav_historical
51129163501rxnav_historical
69189046401rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 5 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TretinoinTRETINOINPar Health USA, LLC9c4ae9d9-c2a0-4995-a27a-e3f0f0284db92026-08-20Boxed warning, Warnings, Adverse reactionsExact identifier
ndc (package): 10370-268-01
ndc (product): 10370-268
ndc11 (package): 10370026801
rxcui: 199159
TretinoinTRETINOINMajor Pharmaceuticals045258e2-5efb-4147-bf74-4c43af04dccc2026-05-26Boxed warning, Warnings, Adverse reactionsExact identifier
ndc (package): 0904-6867-04
ndc (product): 0904-6867
ndc11 (package): 00904686760
ndc11 (package): 00904686704
rxcui: 199159
TretinoinTRETINOINGlenmark Pharmaceuticals Inc., USA264138c1-9e5f-45ef-be87-79ca97c989d92026-01-30Boxed warning, Warnings, Adverse reactionsExact identifier
ndc (package): 68462-792-01
ndc (product): 68462-792
ndc11 (package): 68462079201
rxcui: 199159
TretinoinTRETINOINAmerican Health Packagingb22d5a07-623a-4645-b87d-a151b86da8d52025-10-22Boxed warning, Warnings, Adverse reactionsExact identifier
ndc (package): 68084-075-21
ndc (product): 68084-075
ndc11 (package): 68084007521
ndc11 (package): 68084007511
rxcui: 199159
TretinoinTRETINOINBryant Ranch Prepack7a7974c7-8b6c-41ae-9a48-a08a1439087a2024-07-16Boxed warning, Warnings, Adverse reactionsExact identifier
ndc (package): 72162-1220-3
ndc (package): 72162-1220-1
ndc (product): 72162-1220
ndc11 (package): 72162122003
ndc11 (package): 72162122001
rxcui: 199159

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 5 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
7a7974c7-8b6c-41ae-9a48-a08a1439087atretinoin 10 MG Oral Capsule [PSN] · tretinoin 10 MG Oral Capsule [SCD]2101These highlights do not include all the information needed to use TRETINOIN CAPSULES safely and effectively. See full prescribing information for TRETINOIN CAPSULES . TRETINOIN capsules, for oral use Initial U.S. Approval: 199520240716
9c4ae9d9-c2a0-4995-a27a-e3f0f0284db9tretinoin 10 MG Oral Capsule [PSN] · tretinoin 10 MG Oral Capsule [SCD]217These highlights do not include all the information needed to use TRETINOIN CAPSULES safely and effectively. See full prescribing information for TRETINOIN CAPSULES . TRETINOIN capsules, for oral use Initial U.S. Approval: 199520260310
045258e2-5efb-4147-bf74-4c43af04dccctretinoin 10 MG Oral Capsule [PSN] · tretinoin 10 MG Oral Capsule [SCD]28These highlights do not include all the information needed to use TRETINOIN CAPSULES safely and effectively. See full prescribing information for TRETINOIN CAPSULES. TRETINOIN capsules, for oral use Initial U.S. Approval: 199520250415
b22d5a07-623a-4645-b87d-a151b86da8d5tretinoin 10 MG Oral Capsule [PSN] · tretinoin 10 MG Oral Capsule [SCD]27These highlights do not include all the information needed to use TRETINOIN CAPSULES safely and effectively. See full prescribing information for TRETINOIN CAPSULES. TRETINOIN capsules, for oral use Initial U.S. Approval: 199520251022
264138c1-9e5f-45ef-be87-79ca97c989d9tretinoin 10 MG Oral Capsule [PSN] · tretinoin 10 MG Oral Capsule [SCD]26These highlights do not include all the information needed to use TRETINOIN CAPSULES safely and effectively. See full prescribing information for TRETINOIN CAPSULES. TRETINOIN capsules, for oral use Initial U.S. Approval: 199520260130

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
9c4ae9d9-c2a0-4995-a27a-e3f0f0284db9These highlights do not include all the information needed to use TRETINOIN CAPSULES safely and effectively. See full prescribing information for TRETINOIN CAPSULES . TRETINOIN capsules, for oral use Initial U.S. Approval: 1995Par Health USA, LLC20260820
045258e2-5efb-4147-bf74-4c43af04dcccThese highlights do not include all the information needed to use TRETINOIN CAPSULES safely and effectively. See full prescribing information for TRETINOIN CAPSULES. TRETINOIN capsules, for oral use Initial U.S. Approval: 1995Major Pharmaceuticals20260526
9c4ae9d9-c2a0-4995-a27a-e3f0f0284db9These highlights do not include all the information needed to use TRETINOIN CAPSULES safely and effectively. See full prescribing information for TRETINOIN CAPSULES . TRETINOIN capsules, for oral use Initial U.S. Approval: 1995Par Health USA, LLC20260310
264138c1-9e5f-45ef-be87-79ca97c989d9These highlights do not include all the information needed to use TRETINOIN CAPSULES safely and effectively. See full prescribing information for TRETINOIN CAPSULES. TRETINOIN capsules, for oral use Initial U.S. Approval: 1995Glenmark Pharmaceuticals Inc., USA | Douglas Manufacturing Limited20260130
b22d5a07-623a-4645-b87d-a151b86da8d5These highlights do not include all the information needed to use TRETINOIN CAPSULES safely and effectively. See full prescribing information for TRETINOIN CAPSULES. TRETINOIN capsules, for oral use Initial U.S. Approval: 1995American Health Packaging20251022
045258e2-5efb-4147-bf74-4c43af04dcccThese highlights do not include all the information needed to use TRETINOIN CAPSULES safely and effectively. See full prescribing information for TRETINOIN CAPSULES. TRETINOIN capsules, for oral use Initial U.S. Approval: 1995Major Pharmaceuticals20250415
0f81f505-a962-414e-8612-c3ef3b159e9aThese highlights do not include all the information needed to use TRETINOIN CAPSULES safely and effectively. See full prescribing information for TRETINOIN CAPSULES. TRETINOIN capsules, for oral use Initial U.S. Approval: 1995Teva Pharmaceuticals USA, Inc.20241216
264138c1-9e5f-45ef-be87-79ca97c989d9These highlights do not include all the information needed to use TRETINOIN CAPSULES safely and effectively. See full prescribing information for TRETINOIN CAPSULES. TRETINOIN capsules, for oral use Initial U.S. Approval: 1995Glenmark Pharmaceuticals Inc., USA | Douglas Manufacturing Limited20241129
b22d5a07-623a-4645-b87d-a151b86da8d5Tretinoin Capsules 8207521/0320 Rx onlyAmerican Health Packaging20241029
1e29818c-1937-4e39-957a-4017fa9c6bdcThese highlights do not include all the information needed to use TRETINOIN safely and effectively. See full prescribing information for TRETINOIN. TRETINOIN capsules, for oral use Initial U.S. Approval: 1995H2-Pharma, LLC | CHEPLAPHARM Arzneimittel GmbH20241014
7a7974c7-8b6c-41ae-9a48-a08a1439087aThese highlights do not include all the information needed to use TRETINOIN CAPSULES safely and effectively. See full prescribing information for TRETINOIN CAPSULES . TRETINOIN capsules, for oral use Initial U.S. Approval: 1995Bryant Ranch Prepack20240716
00892887-ad81-414d-a388-08716235fa2cTRETINOIN CapsulesBryant Ranch Prepack20240111
844941d4-f557-42cf-b7fa-5bd7574925f6Tretinoin capsulesBryant Ranch Prepack20240110
d8b55a7c-4d05-08b0-e053-2995a90ae42cTretinoin Capsules Rx OnlyAvKARE20240110
6f8c2985-0241-5ebf-7ed4-4bd9a4ead9c9Tretinoin CapsulesAvKARE20220117
a8d6a61e-7a8c-4219-85c1-eb65062d01f7National Council for Prescription Drug Programs20130213
d27199bb-6cac-49cd-b2ad-99ef40ead23dNational Council for Prescription Drug Programs20120724

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCL01XFRetinoids for cancer treatmentATC1-4tretinoin
ATCD10ADRetinoids for topical use in acneATC1-4tretinoin
FDASPLD012176RetinoidsCHEMhas_chemical_structuretretinoin
FDASPLN0000175607RetinoidEPChas_epctretinoin
MEDRTD010226ParabensCHEMci_chemclasstretinoin
MEDRTD014212TretinoinCHEMhas_ingredienttretinoin
MEDRTD000152Acne VulgarisDISEASEmay_treattretinoin
MEDRTD004342Drug HypersensitivityDISEASEci_withtretinoin
MEDRTD005148Facial DermatosesDISEASEmay_treattretinoin
MEDRTD017495HyperpigmentationDISEASEmay_treattretinoin
MEDRTD015473Leukemia, Promyelocytic, AcuteDISEASEmay_treattretinoin
MEDRTD011247PregnancyDISEASEci_withtretinoin
MEDRTN0000000085Receptor InteractionsMOAhas_moatretinoin
MEDRTN0000009915Unknown Cellular or Molecular InteractionMOAhas_moatretinoin
MEDRTN0000175676Decreased Epithelial ProliferationPEhas_petretinoin
MEDRTN0000009982Decreased Sebaceous Gland ActivityPEhas_petretinoin
MEDRTN0000009979Decreased Sebaceous Gland QuantityPEhas_petretinoin

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH10 MG
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE0
CODESANDAANDA201687
CODESANDAANDA208279
CODESSNOMEDCT327390008
CODESVUID4005223
NAMESPrescribable Synonymtretinoin 10 MG Oral Capsule
SOURCESSourceGold Standard Alchemy
SOURCESSourceMetathesaurus FDA Structured Product Labels
SOURCESSourceMicromedex RED BOOK
SOURCESSourceMultum MediSource Lexicon
SOURCESSourceNational Drug Data File Plus Source Vocabulary
SOURCESSourceUS Edition of SNOMED_CT
SOURCESSourceVeterans Health Administration National Drug File